CD8A and cancer: Post-vaccination, patients exhibited improved immune network connectivity, particularly those with stable disease, characterized by a notable increase in CD8 T cells and B cells, highlighting the vaccine’s efficacy in activating multiple branches of the immune system and its significant impact on cancer treatment (174).